Relay Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Relay Therapeutics, Inc. has filed 494 SEC EDGAR filings since 22 May 2020

SEC filing history

Showing 151-175 of 494 matching filings.

Per page
25
Current page
7
4

4

Filing date
01 Jul 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Jul 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Jul 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39385

144 filing

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39385

144 filing

Filing date
05 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39385

144 filing

Filing date
04 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39385

ARS

Filing date
23 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39385

DEFA14A

Filing date
23 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .